TY - JOUR
T1 - The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis
T2 - Updating the Modified Duke Criteria
AU - Fowler, Vance G.
AU - Durack, David T.
AU - Selton-Suty, Christine
AU - Athan, Eugene
AU - Bayer, Arnold S.
AU - Chamis, Anna Lisa
AU - Dahl, Anders
AU - DiBernardo, Louis
AU - Durante-Mangoni, Emanuele
AU - Duval, Xavier
AU - Fortes, Claudio Querido
AU - Fosbøl, Emil
AU - Hannan, Margaret M.
AU - Hasse, Barbara
AU - Hoen, Bruno
AU - Karchmer, Adolf W.
AU - Mestres, Carlos A.
AU - Petti, Cathy A.
AU - Pizzi, María Nazarena
AU - Preston, Stephen D.
AU - Roque, Albert
AU - Vandenesch, Francois
AU - van der Meer, Jan T. M.
AU - van der Vaart, Thomas W.
AU - Miro, Jose M.
N1 - Funding Information: Acknowledgments. Work contained in this manuscript was made possible by grant 1R01-AI165671 (to V. G. F.) from the National Institutes of Health. J. M. M. received a personal 80:20 research grant from Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–2023. Publisher Copyright: © 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
PY - 2023/8/15
Y1 - 2023/8/15
N2 - The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases (ISCVID) convened a multidisciplinary Working Group to update the diagnostic criteria for IE. The resulting 2023 Duke-ISCVID IE Criteria propose significant changes, including new microbiology diagnostics (enzyme immunoassay for Bartonella species, polymerase chain reaction, amplicon/metagenomic sequencing, in situ hybridization), imaging (positron emission computed tomography with 18F-fluorodeoxyglucose, cardiac computed tomography), and inclusion of intraoperative inspection as a new Major Clinical Criterion. The list of "typical" microorganisms causing IE was expanded and includes pathogens to be considered as typical only in the presence of intracardiac prostheses. The requirements for timing and separate venipunctures for blood cultures were removed. Last, additional predisposing conditions (transcatheter valve implants, endovascular cardiac implantable electronic devices, prior IE) were clarified. These diagnostic criteria should be updated periodically by making the Duke-ISCVID Criteria available online as a "Living Document."
AB - The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases (ISCVID) convened a multidisciplinary Working Group to update the diagnostic criteria for IE. The resulting 2023 Duke-ISCVID IE Criteria propose significant changes, including new microbiology diagnostics (enzyme immunoassay for Bartonella species, polymerase chain reaction, amplicon/metagenomic sequencing, in situ hybridization), imaging (positron emission computed tomography with 18F-fluorodeoxyglucose, cardiac computed tomography), and inclusion of intraoperative inspection as a new Major Clinical Criterion. The list of "typical" microorganisms causing IE was expanded and includes pathogens to be considered as typical only in the presence of intracardiac prostheses. The requirements for timing and separate venipunctures for blood cultures were removed. Last, additional predisposing conditions (transcatheter valve implants, endovascular cardiac implantable electronic devices, prior IE) were clarified. These diagnostic criteria should be updated periodically by making the Duke-ISCVID Criteria available online as a "Living Document."
KW - Duke Criteria
KW - ISCVID
KW - PET/CT
KW - echocardiography
KW - endocarditis
UR - http://www.scopus.com/inward/record.url?scp=85161723724&partnerID=8YFLogxK
U2 - https://doi.org/10.1093/cid/ciad271
DO - https://doi.org/10.1093/cid/ciad271
M3 - Article
C2 - 37138445
SN - 1058-4838
VL - 77
SP - 518
EP - 526
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -